Open Access

Human galectin‑3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions in vivo

  • Authors:
    • Peter Gál
    • Tomáš Vasilenko
    • Ivan Kováč
    • Matúš Čoma
    • Ján Jakubčo
    • Martina Jakubčová
    • Vlasta Peržeľová
    • Lukáš Urban
    • Michal Kolář
    • František Sabol
    • Ján Luczy
    • Martin Novotný
    • Jaroslav Majerník
    • Hans-Joachim Gabius
    • Karel Jr Smetana
  • View Affiliations

  • Published online on: November 27, 2020     https://doi.org/10.3892/mmr.2020.11738
  • Article Number: 99
  • Copyright: © Gál et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Understanding the molecular and cellular processes in skin wound healing can pave the way for devising innovative concepts by turning the identified natural effectors into therapeutic tools. Based on the concept of broad‑scale engagement of members of the family of galactoside‑binding lectins (galectins) in pathophysiological processes, such as cancer or tissue repair/regeneration, the present study investigated the potential of galectins‑1 (Gal‑1) and ‑3 (Gal‑3) in wound healing. Human dermal fibroblasts, which are key cells involved in skin wound healing, responded to galectin exposure (Gal‑1 at 300 or Gal‑3 at 600 ng/ml) with selective changes in gene expression among a panel of 84 wound‑healing‑related genes, as well as remodeling of the extracellular matrix. In the case of Gal‑3, positive expression of Ki67 and cell number increased when using a decellularized matrix produced by Gal‑3‑treated fibroblasts as substrate for culture of interfollicular keratinocytes. In vivo wounds were topically treated with 20 ng/ml Gal‑1 or ‑3, and collagen score was found to be elevated in excisional wound repair in rats treated with Gal‑3. The tensile strength measured in incisions was significantly increased from 79.5±17.5 g/mm2 in controls to 103.1±21.4 g/mm2 after 21 days of healing. These data warrant further testing mixtures of galectins and other types of compounds, for example a combination of galectins and TGF‑β1.
View Figures
View References

Related Articles

Journal Cover

February-2021
Volume 23 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gál P, Vasilenko T, Kováč I, Čoma M, Jakubčo J, Jakubčová M, Peržeľová V, Urban L, Kolář M, Sabol F, Sabol F, et al: Human galectin‑3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions <em>in vivo</em>. Mol Med Rep 23: 99, 2021
APA
Gál, P., Vasilenko, T., Kováč, I., Čoma, M., Jakubčo, J., Jakubčová, M. ... Smetana, K. (2021). Human galectin‑3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions <em>in vivo</em>. Molecular Medicine Reports, 23, 99. https://doi.org/10.3892/mmr.2020.11738
MLA
Gál, P., Vasilenko, T., Kováč, I., Čoma, M., Jakubčo, J., Jakubčová, M., Peržeľová, V., Urban, L., Kolář, M., Sabol, F., Luczy, J., Novotný, M., Majerník, J., Gabius, H., Smetana, K."Human galectin‑3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions <em>in vivo</em>". Molecular Medicine Reports 23.2 (2021): 99.
Chicago
Gál, P., Vasilenko, T., Kováč, I., Čoma, M., Jakubčo, J., Jakubčová, M., Peržeľová, V., Urban, L., Kolář, M., Sabol, F., Luczy, J., Novotný, M., Majerník, J., Gabius, H., Smetana, K."Human galectin‑3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions <em>in vivo</em>". Molecular Medicine Reports 23, no. 2 (2021): 99. https://doi.org/10.3892/mmr.2020.11738